AstraZeneca has been hit with a US class action lawsuit that claims the UK’s largest listed company misled shareholders in connection with investigations by Chinese authorities.
The lawsuit, which AstraZeneca detailed in its annual report on Tuesday, alleges that the company, its chief executive Pascal Soriot, and chief financial officer Aradhana Sarin, made “materially false and misleading statements”, related to the probes.
The lawsuit was filed in December in California, after it had emerged the previous month that Leon Wang, the former executive vice-president of AstraZeneca’s international division, had been detained in China.
您已阅读19%（637字），剩余81%（2728字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。